Ruonan Xu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.
Journal: Antimicrobial agents and chemotherapy
Published: September 04, 2026
Resident eosinophils in patients with chronic obstructive pulmonary disease: a pilot study.
Journal: Frontiers in medicine
Published: February 21, 2026
Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infection.
Journal: Hepatology international
Published: January 06, 2026
Association between primary tumor resection and survival in metastatic intrahepatic cholangiocarcinoma: a retrospective cohort study based on the SEER database.
Journal: Journal of gastrointestinal oncology
Published: October 15, 2025
Factors Affecting Reproductive Outcomes of Hysteroscopic Septum Incision: A Retrospective Cohort Study.
Journal: Journal of minimally invasive gynecology
Published: July 23, 2025
CD300A+ CD8+ T Cells as Predictive Biomarkers for Achieving Functional Cure in Chronic Hepatitis B Patients Undergoing Pegylated Interferon-Alpha Therapy.
Journal: Alimentary pharmacology & therapeutics
Published: March 02, 2025
Efficacy and safety of mesenchymal stem/stromal cells and their derived extracellular vesicles for acute respiratory distress syndrome: a systematic review and meta-analysis.
Journal: Stem cell research & therapy
Published: February 25, 2025
Implications of accumulation of clonally expanded and senescent CD4+GNLY+ T cells in immunological non-responders of HIV-1 infection.
Journal: Emerging microbes & infections
Published: September 06, 2024
Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation.
Journal: Chinese medical journal
Published: August 05, 2024
HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study.
Journal: Emerging microbes & infections
Published: June 27, 2024
Last Updated: 09/26/2026